^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Clear Cell Renal Cell Carcinoma |
| Drug: | Torisel (temsirolimus) (mTOR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
...the NCCN Kidney Cancer Panel has included temsirolimus as a category 1 recommendation, useful under certain circumstances, for first-line treatment of patients with favourable risk features with relapsed or medically unresectable clear cell stage IV RCC.
